Posted on 11/18/20
Horizon Technology Finance Provides $12.5M Venture Loan Facility to Sonex Health
Horizon Technology Finance Corporation (NASDAQ: HRZN), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in . . .
Posted on 11/17/20
Pressure BioSciences Reports Third Quarter 2020 Financial Results and Provides Business Update
Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, services, and platform solutions to the worldwide life . . .
Posted on 11/17/20
Fortune and IBM Watson Health Recognize Top-Performing U.S. Cardiovascular Hospitals
IBM (NYSE: IBM) Watson Health today announced its 2021 Fortune/IBM Watson Health 50 Top Cardiovascular Hospitals list, naming the top-performing U.S. hospitals for inpatient cardiovascular services. This . . .
Posted on 11/17/20
Looking In On LogicBio
SummaryGene-editing concern LogicBio Therapeutics, Inc. has lost ~$90 million of market cap since an IND clinical hold was placed on its LB-001 candidate in February 2020.The . . .
Posted on 11/17/20
Moderna Reports Successful Coronavirus Vaccine Results
On Monday morning, Moderna (NASDAQ:MRNA) released encouraging interim results from a pivotal study with its coronavirus vaccine candidate, mRNA-1273. The company reported its vaccine appears 94.5% . . .
Posted on 11/17/20
Moderna, Zoom Reveal the Nasdaq's Split Personality
Investors have had a lot to wrestle with lately, but on Monday morning, they got some good news. Although other major market benchmarks got most of . . .
Posted on 11/17/20
Warren Buffett Bought 4 Pharma Giants in Q3
Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) filed its Form 13F with the Securities and Exchange Commission on Monday, which gave investors a look at what the Oracle of . . .
Posted on 11/16/20
Frequency Therapeutics Provides Business Updates and Reports Third Quarter 2020 Financial Results
WOBURN, Mass.--(BUSINESS WIRE)--Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a . . .
Posted on 11/16/20
scPharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Business Update
BURLINGTON, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to . . .
Posted on 11/16/20
Nereid Therapeutics Launches: ATP $50M Series A NewCo Co-Founded with Brangwynne
Apple Tree Partners (ATP), a leading life sciences venture firm, today announced the launch of Nereid Therapeutics, a company dedicated to discovering new disease treatments
Posted on 11/16/20
Cerevel Therapeutics Announces Third Quarter 2020 Financial Results and Key Business Highlights
BOSTON, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today . . .
Posted on 11/16/20
Karyopharm Therapeutics: Current Share Price Under-Reflects The Inherent Value
SummaryRecent advancements in readouts for Xpovio and Selinexor have yet to be reflected in market pricing, in our view.Karyopharm has had an in line quarter, where . . .
Posted on 11/16/20
Moderna Finishes Initial Data Collection in Coronavirus Vaccine Trial; Results Could Be Published Soon
Moderna (NASDAQ:MRNA) is now very close to publishing the first results of the crucial late-stage clinical trial for mRNA-1273, the company's COVID-19 vaccine candidate.The company revealed . . .
Posted on 11/16/20
What if Moderna Doesn't Win the Coronavirus Vaccine Race?
Key Points Moderna and rival Pfizer expect phase 3 safety readouts later this month.Pfizer this week said interim phase 3 efficacy data show its vaccine candidate . . .
Posted on 11/13/20
Checkmate Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides an Update on Recent Progress
CAMBRIDGE, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on developing its proprietary technology to harness . . .
Posted on 11/13/20
Forget Moderna: This Is a Stronger Coronavirus Stock
Moderna (NASDAQ:MRNA) could have a good chance of reporting positive news later this month from a late-stage study of coronavirus vaccine candidate mRNA-1273. Pfizer and BioNTech . . .
Posted on 11/13/20
Is CVS Health a Great Dividend Stock?
Dividend stocks can generate significant long-term returns for your portfolio by allowing you to benefit from a rising valuation while collecting recurring cash flow along the . . .
Posted on 11/13/20
Organogenesis Holdings Prices of Public Offering of Class A Common Stock
CANTON, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of . . .
Posted on 11/13/20
Keros Therapeutics Prices of Public Offering of Common Stock
LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments . . .
Posted on 11/12/20
Stoke Therapeutics Reports Third Quarter Financial Results and Provides Business Updates
BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein . . .
Posted on 11/12/20
Axcella Reports Third Quarter 2020 Financial Results and Provides Business Update
AMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella (Nasdaq: AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, . . .
Posted on 11/12/20
Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2020 Financial Results
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel . . .
Posted on 11/12/20
Acer Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate Update
NEWTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for . . .
Posted on 11/12/20
Keros Therapeutics Proposed Public Offering of Common Stock
LEXINGTON, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel . . .
Posted on 11/12/20
Trevi Therapeutics Announces Third Quarter 2020 Financial Results and Business Update
NEW HAVEN, Conn., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of Haduvio . . .
Boston
